NCT00781560已完成不适用
A Cross-sectional Study to Survey the Awareness of Chinese National Adult Lipid Treatment Guideline (2007) and the Rate of Patients (on Treatment) Achieving the Hyperlipidaemia Treatment Goal With Crestor 5mg to 10mg for 8 Weeks
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 2,575
- 试验地点
- 2
- 主要终点
- the awareness rate of Chinese National Adult Lipid Treatment Guideline (2007) by cardiologists
研究概览
简要总结
This study is designed to survey the awareness rate of Chinese National Adult Lipid Treatment Guideline (2007) by cardiologists; To survey the control rate of the patients with dyslipidemia in "real world"; and to evaluate the percentage of hyperlipidemia patients who achieved target LDL-C level according to the Chinese National Adult Lipid Treatment Guideline (2007) following 8-week treatment by Crestor® 5mg or 10mg
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosed as dyslipidemia by doctors
- •Having lipids test and record within one months
- •Diagnosed as hypercholesterolemia or mixed dyslipidaemias and has been prescribed Crestor® 5mg or 10mg
排除标准
- •Unable or unwilling to provide the Inform Consent
结局指标
主要结局
the awareness rate of Chinese National Adult Lipid Treatment Guideline (2007) by cardiologists
时间窗: 1 time
the control rate of patients reaching target LDL-C level
时间窗: 8 weeks
次要结局
- the percent change from baselines in TC, TG, HDL-C(8 weeks)
- the percentage of hyperlipidemia patients in different risk categories who achieved target LDL-C level according to the Chinese National Adult Lipid Treatment Guideline (2007)(8 weeks)
研究者
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Awareness, Care & Treatment In Obesity Management - An Observation in Mainland ChinaObesityNCT05428501Novo Nordisk A/S8,000
已完成
不适用
Centralized Pan-Asian Survey on the Under Treatment of HypercholesterolemiaHypercholesterolemiaNCT00687492AstraZeneca8,000
Unknown
不适用
Dyslipidemia International Survey-Chinathe Prevalence,Lipid Abnormalities,NCT01732952Chinese Society of Cardiology25,000
尚未招募
不适用
A research survey to aware general public in clinical trialsCTRI/2021/12/038650Medanta Institute of Education and Research
已完成
不适用
Lipoprotein(a) in Patients With Cardiovascular Disease (CVD)Cardiovascular Disease and Lipoprotein(a)NCT03887520Novartis Pharmaceuticals49,001